Showing results (461-470 of 999) with videos related to

Sort By:
Pageof 100
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological ManagementFrancesca Spada, Roberta E Rossi, Elda Kara, et al.
ACS Applied Materials & Interfaces|February 4, 2017
Modification of Silver/Single-Wall Carbon Nanotube Electrical Contact Interfaces via Ion IrradiationNathanael D Cox, Cory D Cress, Jamie E Rossi, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|August 7, 2001
[Pseudoallergies]R Bernardini, E Novembre, E Lombardi, et al.
British Medical Journal (Clinical Research Ed.)|November 6, 1982
Haemolytic uraemic syndrome: therapeutic effect of plasma infusionR Misiani, A C Appiani, A Edefonti, et al.
European Journal of Biochemistry|January 15, 1998
Haemoglobin synthesis in erythropoietin-stimulated J2E cells does not require increased numbers of transferrin receptorsB A Callus, S J Busfield, E Rossi, et al.
La Pediatria Medica E Chirurgica : Medical and Surgical Pediatrics|January 1, 1993
[Reduced natural killer function in children with recurrent respiratory tract infections]M E Rossi, S Marranci, A De Marco, et al.
Thrombosis Research|July 28, 2009
Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)A Tosetto, C L Balduini, M Cattaneo, et al.
European Review for Medical and Pharmacological Sciences|July 3, 2026
Oxygen-ozone action on Isaac's syndrome: a case reportL Valdenassi, S Chirumbolo, M T Corsetti, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|July 13, 2010
Nonsurgical extracardiac vascular shunts in the thorax: clinical and imaging characteristicsSantiago Martinez-Jimenez, Laura E Heyneman, H Page McAdams, et al.
Cancer|October 26, 2005
Twelve-year mortality results of a randomized trial of 2 versus 5 years of adjuvant tamoxifen for postmenopausal early-stage breast carcinoma patients (SITAM 01)Maurizio Belfiglio, Miriam Valentini, Fabio Pellegrini, et al.
Pageof 100